Gene Expression Classifier May Reduce Thyroid Surgery Rate
Physicians using gene expression classifier testing said that in 86% of cases, identifying a benign result through testing and potentially avoiding surgery improved patient safety.
Physicians using gene expression classifier testing said that in 86% of cases, identifying a benign result through testing and potentially avoiding surgery improved patient safety.
Second primary malignancies among patients with post-Chernobyl papillary thyroid cancer include hematological malignancies, breast carcinoma, cervical carcinoma, and colon carcinomas.
Thyroid function improved after the researchers placed the child on levothyroxine and supplemented his diet with iodized salt and a multivitamin containing iodine.
Genetic alterations were found in both cancerous and benign samples.
Patients had reduced left middle hippocampus and right anterior hippocampus activity when judging word pairs.
Use of high- and low-dose VB-111 led to 35% and 25% of patients reaching 6-month overall survival, respectively.
Results in this expanded series reaffirm the data in the pilot study and show a 5-year overall survival rate of 43%.
Patients with medullary thyroid cancer taking cabonzantinib lived more than 2 years longer if their tumors had a RET mutation.
New results show no significant associations between dietary habits and thyroid cancer risk.